DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Okamoto A, Sugiyama T, Hamano T. et al.
Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study.
J Clin Oncol 2014;
32: 5507-5507
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.